Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Citi
Chubb
Deloitte
UBS
Julphar

Generated: May 22, 2019

DrugPatentWatch Database Preview

Drug Price Trends for TOBRAMYCIN

« Back to Dashboard

Drug Price Trends for TOBRAMYCIN

Average Pharmacy Cost for TOBRAMYCIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
TOBRAMYCIN 0.3% EYE DROP 70069-0131-01 1.26376 ML 2019-02-20
TOBRAMYCIN 0.3% EYE DROP 17478-0290-10 1.26376 ML 2019-02-20
TOBRAMYCIN 0.3% EYE DROP 61314-0643-05 1.26376 ML 2019-02-20
TOBRAMYCIN-DEXAMETH OPHTH SUSP 61314-0647-25 14.83167 ML 2019-02-20
Drug Name NDC Price/Unit ($) Unit Date

Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for TOBRAMYCIN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
TOBRAMYCIN 300MG/5ML SOLN,INHL,ORAL,5ML,KIT,5 Genericus, Inc. 70644-0899-99 56x5ML 1315.58 2018-08-15 - 2023-08-14 FSS
TOBRAMYCIN 300MG/5ML SOLN,INHL,ORAL,5ML AvKare, Inc. 65162-0914-46 1X56 1924.13 2018-10-30 - 2022-12-31 FSS
TOBRAMYCIN SO4 40MG/ML INJ Golden State Medical Supply, Inc. 17478-0114-30 30ML 18.61 0.62033 ML 2018-01-01 - 2022-12-31 FSS
TOBRAMYCIN 300MG/5ML SOLN,INHL,ORAL,5ML Golden State Medical Supply, Inc. 17478-0340-38 56X5ML 600.00 2018-01-01 - 2022-12-31 FSS
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Teva
McKinsey
Mallinckrodt
Medtronic
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.